nanotechnolog
alreadi
start
significantli
impact
mani
industri
scientif
field
includ
biotechnolog
pharmaceut
food
technolog
semiconductor
nanotechnologybas
tool
devic
includ
highresolut
imag
techniqu
enabl
character
manipul
materi
nanolevel
elucid
nanoscal
phenomena
equip
us
abil
fabric
novel
materi
structur
one
promis
impact
nanotechnolog
area
nanotherapi
employ
nanosystem
dendrim
nanoliposom
niosom
nanotub
emuls
quantum
dot
nanotherapi
lead
toward
concept
person
medicin
potenti
earli
diagnos
coupl
effici
target
therapi
develop
smart
target
nanocarri
deliv
bioactiv
control
rate
directli
design
cell
tissu
provid
better
efficaci
reduc
side
effect
nanocarri
improv
solubl
bioactiv
allow
deliveri
smallmolecul
drug
also
deliveri
nucleic
acid
protein
review
focu
nanoscal
bioactiv
deliveri
target
mechan
role
highresolut
imag
techniqu
evalu
develop
nanocarri
nanotechnolog
multidisciplinari
approach
employ
vast
divers
array
tool
techniqu
deriv
engin
physic
chemistri
biolog
sahoo
et
al
within
past
decad
flurri
new
research
develop
patent
applic
around
nanosc
technolog
health
area
one
princip
area
nanotechnolog
nanomedicin
accord
nation
institut
health
nih
nanomedicin
roadmap
initi
refer
highli
specif
medic
intervent
molecular
scale
diagnosi
prevent
treatment
diseas
nih
roadmap
initi
http
nihroadmapnihgovinitiativesasp
nanomedicin
signific
potenti
revolution
diagnost
therapeut
premis
develop
smart
nanodevic
overal
object
nanomedicin
medicin
diagnos
accur
earli
possibl
treat
effect
possibl
without
side
effect
evalu
efficaci
treatment
noninvas
caruth
et
al
bioactiv
deliveri
nanosystem
nanocarri
gener
drug
deliveri
particular
constitut
signific
domain
nanomedicin
drug
formul
oral
inject
deliveri
rout
alway
effici
rout
particular
therapi
new
bioactiv
materi
nucleic
acid
protein
requir
novel
deliveri
technolog
minim
side
effect
lead
better
patient
complianc
hugh
hand
reformul
wwwelseviercomlocatemicron
micron
old
drug
reduc
side
effect
increas
patient
complianc
thu
save
money
health
care
system
furthermor
drug
candid
pass
trial
phase
reformul
use
new
carrier
system
advanc
nanosci
technolog
made
possibl
manufactur
character
submicrometr
bioactiv
carrier
routin
basi
deliveri
bioactiv
variou
site
within
bodi
releas
behavior
directli
affect
particl
size
compar
micrometers
carrier
nanocarri
provid
surfac
area
potenti
increas
solubl
enhanc
bioavail
improv
timecontrol
releas
enabl
precis
target
entrap
compound
greater
extent
mozafari
consequ
improv
stabil
target
amount
materi
requir
specif
effect
encapsul
incorpor
nanocarri
much
less
amount
requir
unencapsul
particularli
use
deal
expensiverar
bioactiv
materi
time
target
releas
improv
effect
bioactiv
compound
broaden
applic
rang
ensur
optim
dosag
therebi
improv
costeffect
product
gener
reactiv
sensit
materi
polynucleotid
polypeptid
turn
stabl
ingredi
encapsul
entrap
nanocarri
system
mozafari
innov
nanocarri
make
possibl
use
certain
chemic
biolog
previous
impract
toxic
imposs
administ
exampl
bioactiv
target
enabl
deliveri
chemotherapi
agent
directli
tumor
reduc
system
side
effect
hugh
scientist
investig
new
way
deliv
macromolecul
facilit
develop
new
biolog
product
bioblood
protein
biovaccin
similarli
success
dna
rna
therapi
depend
innov
bioactiv
deliveri
techniqu
elane
mani
occas
success
bioactiv
compound
depend
deliveri
method
import
exemplifi
presenc
compani
base
unit
state
alon
involv
develop
bioactiv
deliveri
platform
daquino
note
effect
bioactiv
carrier
rang
nanosystem
eg
drugpolym
conjug
polymer
micel
microparticl
rang
mm
nanoand
microscal
system
extrem
import
develop
variou
clinic
use
bioactiv
deliveri
system
instanc
microcarri
use
bioactiv
target
certain
part
pulmonari
tract
system
target
tumor
nanocarri
effectu
practic
reason
perspect
nanotechnolog
includ
microtechnolog
nanofabr
nanomanufactur
micro
counterpart
park
describ
nanotechnolog
manufactur
nano
microdrug
deliveri
system
manufactur
nanomicro
particl
capsul
taken
exampl
current
method
prepar
nanomicroparticl
mainli
base
doubl
emuls
method
solvent
exchang
techniqu
freita
et
al
main
problem
method
low
drug
load
capac
low
load
effici
poor
abil
control
size
distribut
util
nanotechnolog
nanopattern
could
allow
manufactur
nanomicroparticl
high
load
effici
monodispers
size
distribut
park
review
focus
potenti
nanotechnolog
nanotherapi
includ
recent
statu
nanocarri
bioactiv
deliveri
diagnost
role
highresolut
microscopi
regard
technolog
extend
limit
current
molecular
diagnost
permit
develop
person
medicin
nanotechnolog
rel
new
disciplin
although
full
scope
contribut
field
human
health
care
remain
unexplor
recent
advanc
suggest
nanotechnolog
profound
impact
diseas
prevent
diagnosi
treatment
cheng
et
al
emerich
sahoo
labhasetwar
william
applic
nanotechnolog
medicin
particularli
promis
area
molecular
imag
diseas
diagnosi
bioactiv
encapsul
target
deliveri
specif
site
bodi
intens
investig
product
undergo
clinic
trial
moghimi
et
al
shaffer
wilkinson
encapsul
target
bioactiv
agentsinclud
drug
vaccin
nutrient
cosmet
protect
degrad
inactiv
investig
extens
use
microencapsul
system
howev
provid
target
control
releas
key
function
provid
much
effici
employ
nanocarri
technolog
mozafari
mani
current
nanocarri
system
fact
convent
drug
deliveri
system
happen
nanomet
rang
nanoliposom
polymer
micel
nanoparticl
dendrim
niosom
nanocryst
park
addit
reduc
frequenc
drug
administr
thu
improv
patient
comfort
novel
deliveri
system
would
offer
protect
improv
pharmacokinet
easili
degrad
compound
peptid
polynucleotid
often
short
halfliv
vivo
oriv
et
al
pharmaceut
industri
field
bioactiv
deliveri
repres
strateg
tool
expand
drug
market
new
deliveri
technolog
could
reformulaterepackag
classic
drug
offer
competit
edg
upcom
patent
expir
avoid
competit
gener
noteworthi
current
global
pharmaceut
market
relat
sale
product
includ
bioactiv
deliveri
system
mazzola
effici
bioactiv
deliveri
variou
part
bodi
directli
affect
particl
size
nanostructuremedi
bioactiv
deliveri
key
technolog
realiz
nanotherapi
potenti
enhanc
bioavail
improv
time
releas
bioactiv
molecul
enabl
precis
target
dass
su
dubin
nanoscal
deliveri
system
appli
pulmonari
therapi
courrier
et
al
gene
deliveri
vector
senior
mozafari
et
al
stabil
bioactiv
would
otherwis
degrad
rapidli
lavan
et
al
lavan
et
al
addit
benefit
use
target
nanocarri
reduc
toxic
effici
distribut
bioactiv
materi
ravi
kumar
anatom
featur
blood
brain
barrier
branch
pathway
pulmonari
tract
tight
epitheli
junction
skin
make
difficult
bioactiv
reach
mani
desir
physiolog
target
nanocarri
help
penetr
overcom
barrier
bioactiv
deliveri
hugh
mani
bioactiv
materi
poorli
water
solubl
result
low
bioavail
micel
current
investig
carrier
vehicl
poorli
solubl
hydrophob
bioactiv
torchilin
micel
solubil
drug
incorpor
hydrophob
core
thu
increas
bioavail
microemuls
also
investig
potenti
serv
drug
carrier
vehicl
sinc
oil
phase
contain
high
payload
hydrophob
drug
bagw
et
al
lawrenc
ree
anoth
possibl
encapsul
control
releas
lipidsolubl
agent
use
lipid
carrier
high
lipidphas
waterphas
ratio
onionshap
liposom
form
multilamellar
vesicl
mlv
deliveri
polynucleotid
import
new
class
bioactiv
describ
separ
section
anatom
chang
pathophysiolog
condit
diseas
inflam
tissu
offer
opportun
deliveri
variou
nanotechnolog
product
bioactiv
target
achiev
take
advantag
specif
characterist
abnorm
tissu
ideal
target
system
long
circul
time
present
suffici
concentr
target
site
lose
activ
therapeut
efficaci
circul
sahoo
et
al
increas
vascular
permeabl
coupl
impair
lymphat
drainag
tumor
allow
enhanc
permeabl
retent
effect
nanosystem
tumor
inflam
tissu
hashizum
et
al
mcdonald
baluk
maeda
et
al
matsumura
maeda
therefor
pathophysiolog
opportun
allow
extravas
nanosystem
select
local
inflam
tissu
allen
culli
hobb
et
al
fig
tendenc
nanosystem
specif
local
reticuloendotheli
system
also
present
excel
opportun
passiv
target
therapeut
agent
macrophag
present
liver
spleen
natur
system
therefor
use
bioactiv
target
intracellular
infect
candiasi
leishmaniasi
listeria
macrophag
infect
individu
play
role
diseas
consequ
macrophag
destroy
diseas
well
daemen
et
al
davi
import
bodi
organ
consid
sitespecif
nanotherapi
brain
howev
therapeut
valu
mani
promis
bioactiv
treatment
variou
neurolog
disord
diminish
presenc
bloodbrain
barrier
calvo
et
al
bloodbrain
barrier
uniqu
membran
tightli
segreg
brain
circul
blood
pardridg
result
effici
protect
bioactiv
deliveri
brain
challeng
nanotechnolog
offer
solut
use
numer
chemic
entiti
treat
brain
disord
otherwis
clinic
use
presenc
bloodbrain
barrier
nanoparticl
effect
use
deliv
relev
therapeut
brain
alyautdin
et
al
garciagarcia
et
al
encapsul
bioactiv
nanoparticl
modifi
cell
tissu
distribut
lead
select
deliveri
biolog
activ
compound
improv
therapeut
efficaci
reduc
toxic
de
kozak
et
al
feng
et
al
kattan
et
al
consequ
variou
nanosystem
success
use
new
bioactiv
carrier
deliveri
brain
recent
studi
visser
et
al
studi
target
pegyl
liposom
load
horseradish
peroxidas
tag
transferrin
bloodbrain
barrier
vitro
obtain
effect
target
liposom
load
protein
peptid
drug
brain
capillari
endotheli
cell
suggest
system
attract
approach
drug
deliveri
brain
enhanc
uptak
effici
also
shown
gastrointestin
absorpt
desai
hussain
et
al
transcutan
permeat
kohli
alpar
particl
around
nm
nm
size
respect
howev
small
particl
travel
lung
may
also
greater
chanc
exhal
larger
compartment
multilay
bioactiv
carrier
help
deliveri
pulmonari
extrem
instanc
outer
layer
carrier
architectur
may
formul
biodegrad
carrier
travel
pulmonari
tract
carrier
penetr
lung
addit
shed
allow
encapsul
materi
releas
biodegrad
nanoparticl
gelatin
human
serum
albumin
show
promis
bioactiv
deliveri
lung
brzoska
et
al
anoth
major
site
bioactiv
transport
target
skin
skin
act
key
target
well
principl
barrier
topicaltransderm
tt
bioactiv
deliveri
topic
transderm
deliveri
rout
drug
administr
advantag
pathway
includ
avoid
hepat
first
pass
effect
continu
drug
deliveri
fewer
side
effect
improv
patient
complianc
barri
interest
pharmaceut
cosmet
industri
skin
deliveri
prompt
develop
investig
wide
varieti
carrier
system
differ
physicochem
characterist
major
obstacl
tt
drug
deliveri
low
percutan
penetr
stratum
corneum
provid
principl
barrier
tt
deliveri
appli
bioactiv
consist
corneocyt
embed
intercellular
lipid
matrix
compos
ceramid
free
fatti
acid
cholesterol
schurer
elia
sever
approach
use
weaken
skin
barrier
improv
tt
bioactiv
deliveri
choi
maibach
elia
et
al
william
barri
among
effici
tt
bioactiv
deliveri
nanotechnolog
approach
employ
elast
vesicl
ethosom
nanometr
size
rang
elsay
et
al
lopezpinto
et
al
studi
pig
skin
lopez
et
al
employ
highresolut
lowtemperatur
scan
electron
microscopi
order
detect
effect
nanoliposom
ca
nm
averag
size
protect
stratum
corneum
sc
nonion
surfact
imag
techniqu
enabl
visual
nativ
treat
sc
incub
nanoliposom
octyl
glucosid
without
caus
damag
sc
sampl
prepar
microscop
investig
lopez
et
al
inadequaci
convent
drug
treatment
mani
exist
health
problem
emerg
new
challeng
includ
acquir
immunodefici
syndrom
aid
sever
acut
respiratori
syndrom
sar
make
requir
potent
therapeut
formul
matter
urgenc
new
class
bioactiv
therapeut
agent
base
polynucleotid
molecul
increas
knowledg
genom
molecul
also
known
nucleic
acid
drug
potenti
offer
heal
human
anim
diseas
caus
rather
treat
symptom
import
particularli
case
hereditari
diseas
make
sure
treat
sourc
pass
next
gener
mozafari
et
al
polynucleotidebas
therapeut
plasmid
contain
transgen
use
gene
therapi
antisens
antigen
oligonucleotid
ribozym
dnazym
dna
rna
aptam
small
interf
rna
sirna
develop
past
year
crook
mortazavi
et
al
stull
szoka
ulrich
et
al
although
polynucleotidebas
bioactiv
earli
stage
clinic
trial
emerg
recent
year
promis
therapeut
candid
abl
act
larg
rang
diseas
hereditari
disord
cancer
neurolog
cardiovascular
disord
aid
viral
infect
mozafari
et
al
stull
szoka
ulrich
et
al
past
two
decad
clinic
studi
gene
therapi
report
gene
therapi
identifi
procedur
use
insert
exogen
polynucleotid
dna
mrna
oligonucleotid
cell
tissu
cure
diseas
improv
associ
symptom
ruozi
et
al
gene
therapi
start
choic
therapeut
gene
although
critic
object
success
gene
transfer
target
tissu
nanotechnolog
play
crucial
role
due
limit
abil
nake
dna
enter
cell
suscept
enzymat
degrad
gene
transfer
transfect
mainli
achiev
use
deliveri
vector
three
main
type
gene
deliveri
system
describ
viral
vector
nonvir
vector
form
nanoparticl
liposom
dendrim
direct
inject
genet
materi
tissu
use
socal
gene
gun
goverdhana
et
al
labhasetwar
mortazavi
et
al
mozafari
et
al
viral
vector
attract
term
scientif
strategi
exploit
natur
target
mechan
virus
acquir
cours
evolut
result
viral
vector
base
retrovirus
adenovirus
virus
current
effici
method
dna
transfer
cell
howev
vector
could
suffer
seriou
difficulti
effect
pharmaceut
process
scaleup
possibl
revers
engin
viru
wild
type
sahoo
et
al
furthermor
viral
vector
drawback
risk
recombin
immunogen
carcinogen
crystal
tripathi
et
al
therefor
synthet
vector
potenti
advantag
gene
transfer
even
show
lower
effici
viral
system
liposom
nanoliposom
particular
cation
one
becom
one
studi
synthet
nonvir
vector
frequent
use
human
gene
therapi
audouy
et
al
eastman
scheul
igarashi
et
al
abil
cation
liposom
mediat
transfect
attribut
intrins
properti
system
name
spontan
electrostat
interact
posit
charg
vesicl
neg
charg
dna
molecul
ensur
effici
condens
polynucleotid
modifi
lipid
composit
liposomepolynucleotid
complex
exhibit
appropri
charg
enhanc
possibl
cellular
uptak
case
cation
liposom
fusion
endocytosi
propos
mechan
dna
oligonucleotid
uptak
de
lima
et
al
efficaci
use
system
vivo
gene
transfer
biolog
physicochem
properti
liposomesdna
complex
must
elucid
microscop
techniqu
proven
use
imag
clarifi
factor
composit
carrierdna
ratio
configur
size
polydispers
affect
assembl
stabil
vector
gene
transfer
abil
recent
anion
nanoliposom
becom
popular
polynucleotid
deliveri
vehicl
due
toxic
complic
associ
cation
agent
mozafari
et
al
mortazavi
et
al
method
incorpor
polynucleotid
similarli
charg
anion
liposom
mediat
dival
cation
report
develop
mozafari
cowork
sinc
kahveci
et
al
zhdanov
et
al
mozafari
zarei
et
al
mozafari
et
al
mozafari
et
al
mozafari
et
al
mortazavi
et
al
group
studi
structur
ternari
complex
liposomeca
dna
morpholog
use
scan
probe
microscop
zarei
et
al
addit
mechan
calciuminduc
dna
interact
liposom
contain
zwitterion
lipid
well
contain
anion
lipid
studi
use
light
scatter
differ
microscop
techniqu
zarei
et
al
problem
toxic
scaleup
industri
level
address
new
techniqu
call
heat
method
develop
mozafari
et
al
mozafari
et
al
mortazavi
et
al
potenti
toxic
solvent
deleteri
procedur
involv
applic
nanotechnolog
human
gene
therapi
review
extens
davi
describ
nonvir
vector
base
nanoparticl
usual
nm
size
employ
transport
plasmid
dna
emphas
nanotechnolog
gene
therapi
would
appli
replac
current
use
viral
vector
potenti
less
immunogen
nanos
polynucleotid
carrier
use
highresolut
scan
probe
imag
studi
lipid
gene
transfer
vector
interact
liposom
dna
molecul
recent
review
mozafari
et
al
liposom
carrier
system
use
bioactiv
transport
target
nanotherapi
explain
follow
section
lipidbas
carrier
system
includ
liposom
nanovers
nanoliposom
among
promis
encapsul
technolog
employ
rapidli
develop
field
nanotechnolog
compar
encapsul
strategi
chitosanand
alginatebas
carrier
lipidbas
nanoencapsul
system
unparallel
advantag
includ
abil
entrap
materi
differ
solubl
possibl
produc
use
natur
ingredi
industri
scale
target
bummer
mozafari
et
al
yurdugul
mozafari
lipidbas
carrier
shield
ingredi
free
radic
metal
ion
ph
enzym
might
otherwis
result
degrad
bioactiv
compound
impart
stabil
watersolubl
materi
particularli
high
wateract
applic
gouin
accommod
watersolubl
materi
also
lipidsolubl
agent
requir
simultan
provid
synergist
effect
suntr
shek
anoth
uniqu
properti
lipidbas
nanocarri
target
deliveri
content
specif
area
within
bodi
well
nonliv
system
addit
lipid
base
nanocarri
may
target
requir
site
insid
bodi
via
activ
eg
incorpor
antibodi
passiv
eg
target
base
particl
size
mechan
mozafari
mortazavi
main
lipidbas
nanoencapsul
system
use
protect
deliveri
variou
bioactiv
materi
explain
word
liposom
deriv
two
greek
word
lipo
fat
soma
bodi
structur
mean
structur
fatti
envelop
encapsul
aqueou
core
compart
recent
definit
propos
confer
field
liposomolog
describ
liposom
close
continu
bilay
structur
made
mainli
lipid
andor
phospholipid
molecul
mozafari
et
al
mozafari
mortazavi
intens
investig
develop
pharmaceut
cosmet
food
industri
microand
nanocarri
system
protect
deliveri
bioactiv
agent
recent
studi
suggest
liposom
even
natur
present
first
food
take
breast
milk
keller
et
al
keller
liposom
compos
one
lipid
andor
phospholipid
bilay
contain
molecul
protein
polym
structur
liposom
compos
number
concentr
bilay
known
multilamellar
vesicl
mlv
one
compos
mani
small
nonconcentr
vesicl
encapsul
within
singl
lipid
bilay
known
multivesicular
vesicl
mvv
anoth
type
liposom
known
unilamellar
vesicl
ulv
contain
singl
lipid
bilay
fig
owe
possess
lipid
aqueou
phase
liposom
util
entrap
deliveri
releas
watersolubl
lipidsolubl
materi
term
nanoliposom
recent
introduc
exclus
refer
nanoscal
lipid
vesicl
mozafari
mortazavi
sinc
liposom
gener
word
cover
mani
class
lipid
vesicl
whose
diamet
rang
around
nm
sever
micromet
nanoliposom
possess
physic
structur
thermodynam
properti
liposom
describ
manufactur
liposom
nanoliposom
requir
input
energi
dispers
lipidphospholipid
molecul
aqueou
medium
mozafari
mortazavi
underli
mechan
format
liposom
nanoliposom
basic
hydrophilichydrophob
interact
phospholipid
water
molecul
mozafari
sinc
liposom
dynam
entiti
tend
aggreg
andor
fuse
result
increas
size
vesicl
prepar
nanometr
size
rang
may
end
becom
micrometr
particl
upon
storag
howev
nanoliposom
suffici
stabil
maintain
size
could
defin
bilay
lipid
vesicl
possess
maintain
nanometr
size
rang
storag
applic
mozafari
mortazavi
uniqu
properti
liposom
trigger
numer
applic
differ
field
scienc
technolog
basic
studi
membran
structurefunct
bioactiv
agent
deliveri
liposom
nanoliposom
particularli
use
effici
bioactiv
deliveri
devic
abil
pass
lipid
bilay
cell
membran
target
therapi
also
achiev
effici
via
liposom
nanoliposom
employ
passiv
activ
target
mechan
mozafari
mortazavi
mozafari
activ
target
achiev
engin
carrier
sensit
differ
stimuli
eg
ph
temperatur
light
etc
conjug
bioactivecarri
system
one
target
ligand
tissu
cellspecif
molecul
recent
studi
zhang
et
al
show
pegyl
treat
polyethylen
glycol
liposom
link
monoclon
antibodi
human
insulin
receptor
led
widespread
report
express
brain
rhesu
monkey
passiv
target
hand
use
natur
cours
follow
bioactivecarri
complex
upon
introduc
bodi
method
sitespecif
deliveri
releas
bioactiv
agent
therefor
base
physicochem
properti
bioactivecarri
complex
physioanatom
condit
bodi
clearanc
kinet
vivo
biodistribut
carrier
system
depend
physicochem
factor
like
size
charg
hydrophob
manipul
enabl
passiv
target
archaeosom
liposom
made
one
polar
ether
lipid
extract
domain
archaea
archaeobacteria
mani
archaea
live
environ
includ
high
salt
concentr
low
ph
valu
high
temperatur
henc
membran
structur
uniqu
enabl
surviv
hostil
condit
core
lipid
polar
head
group
remov
archaea
consist
archaeol
diether
caldarchaeol
tetraeth
wherein
regularli
branch
repeat
unit
form
isoprenoid
chain
usual
carbon
per
chain
archaeol
carbon
per
chain
caldarchaeol
attach
via
ether
bond
posit
glycerol
carbon
contrast
core
lipid
found
bacteria
eucarya
consist
unbranch
mostli
fatti
acyl
chain
often
unsatur
attach
via
ester
bond
glycerol
carbon
polar
moieti
archaeol
monopolar
caldarchaeol
bipolar
similar
phospho
glyco
polyol
amino
hydroxyl
group
encount
ester
lipid
phosphatidylcholin
rare
present
archaeal
lipid
patel
et
al
although
archaeosom
recent
technolog
alreadi
proven
safe
deliveri
system
bioactiv
agent
includ
drug
vaccin
patel
chen
compar
liposom
made
ester
phospholipid
archaeosom
rel
thermost
resist
oxid
chemic
enzymat
hydrolysi
also
resist
low
ph
bile
salt
would
encount
gastrointestin
tract
archaeosom
prepar
total
polar
lipid
extract
individu
purifi
polar
lipid
show
promis
adjuv
promot
strong
humor
cytotox
tcell
respons
encapsul
solubl
antigen
therefor
great
potenti
use
archaeosom
drug
vaccin
bioactiv
materi
deliveri
applic
case
liposom
possibl
incorpor
ligand
polym
archaeosom
shown
incorpor
polyethyleneglycol
coenzym
archaeosom
alter
tissu
distribut
profil
intraven
administ
vesicl
omri
et
al
recent
report
intraven
oral
deliveri
nanometrics
archaeosom
anim
model
well
toler
appar
toxic
omri
et
al
result
studi
promis
util
archaeosom
encapsul
deliveri
differ
bioactiv
compound
cochleat
smallsiz
stabl
lipidbas
carrier
compris
mainli
neg
charg
lipid
eg
phosphatidylserin
dival
cation
calcium
zarif
cigarshap
multilay
structur
consist
continu
solid
lipid
bilay
sheet
roll
spiral
shape
littl
intern
aqueou
space
hydrophob
amphiphil
neg
posit
charg
molecul
deliv
cochleat
cochleat
submicron
version
ie
nanocochl
use
deliv
protein
peptid
dna
vaccin
gene
therapi
applic
abl
cover
unpleas
tast
smell
bioactiv
materi
intend
oral
deliveri
mannino
gouldfogerit
mozafari
et
al
due
nanometr
size
stabil
resist
degrad
gastrointestin
tract
nanocochl
reveal
great
potenti
deliv
bioactiv
agent
oral
parenter
mannino
gouldfogerit
zarif
cochleat
contain
amphotericin
b
amb
develop
enter
phase
clinic
trial
oral
parenter
treatment
fungal
infect
zarif
uniqu
structur
properti
cochleat
make
ideal
candid
oral
system
deliveri
sensit
materi
includ
peptid
nucleic
acid
drug
polym
materi
potenti
possess
sever
desir
properti
use
nanocarri
includ
biocompat
biodegrad
function
capabl
function
structur
manipul
polym
materi
bioactiv
molecul
incorpor
within
polym
entrap
encapsul
drug
within
polym
allow
greater
control
pharmacokinet
behavior
bioactiv
molecul
hugh
bioactiv
releas
ideal
near
zeroord
kinet
profil
establish
constant
flow
encapsul
substanc
carrier
pharmacokinet
behavior
maintain
appropri
steadi
level
bioactiv
materi
site
deliveri
contrast
convent
oral
deliveri
typic
follow
firstord
releas
kinet
releas
rate
proport
amount
materi
remain
carrier
landgraf
et
al
compar
releas
kinet
antiinflammatori
agent
taken
oral
use
macropor
copolym
carrier
micropor
copolym
carrier
contain
nanochannel
macropor
bioactiv
carrier
releas
encapsul
initi
burst
follow
firstord
releas
kinet
micropor
carrier
structur
nanochannel
steadili
releas
biomateri
near
zeroord
fashion
techniqu
use
coupl
bioactiv
polym
includ
sequest
conjug
micel
format
duncan
ulrich
et
al
review
biodegrad
polymer
materi
show
promis
bioactiv
deliveri
applic
biodegrad
polym
nanoparticl
typic
consist
polylact
acid
pla
polyglycol
acid
pga
copolym
pla
pga
investig
deliveri
polynucleotid
polypeptid
vaccin
anticanc
therapeut
ocular
drug
cytokin
hugh
polym
investig
nanoscal
bioactiv
carrier
includ
polyalkylcyanoacryl
poli
acid
phb
poli
organophosphazen
poli
ethylen
glycol
peg
poli
caprolacton
pcl
poli
ethylen
oxid
peo
copolym
plapeg
synthet
polym
peg
use
encapsul
biolog
materi
creat
stabl
nanocarri
hugh
one
exampl
hybrid
drug
carrier
liposom
coat
peg
call
stealth
liposom
convent
liposom
nanoliposom
typic
clear
rapidli
blood
circul
stealth
liposom
peg
coat
prolong
circul
time
moghimi
szebeni
mechan
behind
prolong
circul
still
investig
furthermor
polym
use
enhanc
releas
characterist
carrier
system
case
coat
tablet
hydroxypropyl
methylcellulos
phthalat
hpmcp
nanoparticl
kim
et
al
nanoparticleco
tablet
show
decreas
releas
rate
migrat
toward
zeroord
releas
kinet
particl
size
decreas
dendrim
uniqu
class
polym
provid
anoth
avenu
nanodeliveri
differ
bioactiv
compound
word
dendrim
deriv
greek
word
dendri
tree
branchlik
mero
part
gardiki
et
al
dendrim
consid
highli
branch
macromolecul
small
size
low
polydispers
contribut
reproduc
pharmacokinet
behavior
cloning
dendrim
fabric
monom
use
either
converg
diverg
stepgrowth
polymer
welldefin
structur
monodispers
size
surfac
function
capabl
stabil
properti
dendrim
make
attract
nanocarri
candid
hugh
ideal
dendrim
bioactiv
deliveri
system
howev
must
also
nontox
nonimmunogen
biodegrad
review
see
aulenta
et
al
first
complet
dendrim
famili
synthes
character
commerci
poli
amidoamin
pamam
dendrim
character
safe
nonimmunogen
nanocarri
use
deliveri
drug
antisens
nucleotid
gene
therapi
vitro
vivo
frechet
tomalia
bioactiv
molecul
associ
dendrim
via
either
complex
encapsul
schemat
shown
fig
conjug
carrier
system
compos
dendrim
liposom
recent
manufactur
character
gardiki
et
al
niosom
vesicl
made
nonion
surfact
molecul
develop
control
deliveri
system
order
overcom
problem
associ
nanocarri
steril
largescal
product
stabil
liposomelik
vesicl
form
hydrat
mixtur
cholesterol
charg
induc
molecul
nonion
surfact
monoalkyl
dialkyl
polyoxyethylen
ether
assembl
close
bilay
case
liposomesnanoliposom
mozafari
mortazavi
niosom
spontan
thermodynam
stabl
vesicl
form
presenc
proper
mixtur
surfact
charg
induc
agent
mechan
vesicl
format
upon
use
nonion
surfact
complet
clear
common
theori
nonion
surfact
form
close
bilay
aqueou
media
base
amphiphil
natur
format
structur
involv
input
energi
instanc
mean
physic
agit
eg
use
handshak
method
see
bailli
et
al
heat
eg
use
heat
method
see
mozafari
mozafari
et
al
mozafari
et
al
close
bilay
structur
hydrophob
part
molecul
orient
away
aqueou
solvent
wherea
hydrophil
head
come
contact
aqueou
solvent
niosom
resembl
phospholipid
vesicl
liposom
nanoliposom
henc
enabl
entrap
hydrophil
hydrophob
materi
low
cost
stabil
result
eas
storag
nonion
surfact
led
exploit
compound
altern
phospholipid
uchegbu
vya
niosom
entrap
hydrophil
drug
bioactiv
upon
encapsul
hydrophob
materi
partit
molecul
hydrophob
domain
vesicl
formul
either
unilamellar
multilamellar
structur
moreov
niosom
possess
great
stabil
costeffect
simpl
methodolog
routin
largescal
product
without
use
hazard
solvent
uchegbu
et
al
uchegbu
et
al
studi
differ
phase
morpholog
niosom
eg
discom
polyhedr
niosom
employ
confoc
laser
scan
microscopi
microscop
examin
enabl
observ
identif
spheric
helic
tubular
polyhedr
niosom
review
see
uchegbu
vya
along
convent
polymerand
liposomebas
formul
siliconbas
nanocarri
emerg
field
bioactiv
encapsul
target
ferrari
commonli
investig
siliconbas
materi
bioactiv
deliveri
porou
silicon
silica
silicon
dioxid
architectur
includ
calcifi
nanopor
platinumcontain
nanopor
porou
nanoparticl
nanoneedl
hugh
porou
silicon
discov
year
ago
sinc
attract
much
interest
demonstr
photoluminesc
room
temperatur
culli
et
al
vaccari
et
al
two
aspect
porou
silicon
particular
relev
vivo
applic
name
use
sensit
biosensor
protein
antigen
dna
ii
modifi
wide
rang
biolog
organ
molecul
featur
allow
porou
silicon
serv
versatil
biomateri
although
effort
area
still
earli
development
stage
combin
biocompat
materi
highli
biosensit
capabl
lead
new
applic
tissuebas
bioassay
bioactiv
deliveri
healthmonitor
applic
demonstr
porou
silicon
biodegrad
physiolog
environ
canham
dissolut
rate
depend
medium
acid
porou
silicon
morpholog
poros
chemic
surfac
derivat
open
way
applic
biomedicin
eg
see
vaccari
et
al
basic
sens
porou
silicon
network
air
hole
within
interconnect
crystallin
silicon
matrix
free
volum
insid
pore
load
bioactiv
releas
bodi
follow
dissolut
matrix
idea
guidelin
follow
design
implant
microsystem
prototyp
anticanc
devic
releas
doxorubicin
treatment
tumor
minotti
et
al
vaccari
et
al
order
mesopor
silica
materi
high
surfac
area
larg
pore
volum
appear
new
member
famili
silicabas
materi
beck
et
al
pore
size
distribut
mesopor
silica
narrow
modul
mesopor
region
sever
nanomet
expand
avail
pore
size
zeolit
properti
would
make
materi
potenti
interest
novel
carrier
larg
drug
molecul
nm
recent
consider
investig
carri
applic
mesopor
silica
nanocarri
system
high
bioactiv
load
capac
sustain
control
releas
xue
shi
tang
et
al
exampl
therapi
investig
use
siliconbas
deliveri
system
includ
porou
silicon
embed
platinum
antitumor
agent
calcifi
porou
silicon
design
artifici
growth
factor
silicon
nanopor
antibodi
deliveri
porou
silica
nanoparticl
contain
antibiot
enzym
dna
review
see
hugh
carbon
nanostructur
receiv
much
attent
recent
year
hollow
cagelik
architectur
known
nanotub
fulleren
also
call
buckybal
spheric
structur
resembl
geodes
dome
buckminst
fuller
hugh
singlewal
nanotub
multiwal
nanotub
fulleren
common
configur
size
geometri
surfac
characterist
structur
make
attract
applic
nanocarri
system
carbon
nanotub
light
spot
nanosci
nanotechnolog
owe
except
physic
properti
zanella
et
al
electron
properti
singlewal
carbon
nanotub
remark
insofar
either
metal
semiconduct
depend
n
indic
chiral
saito
et
al
nanotub
stabl
molecul
chemic
inert
due
strong
coval
sp
bond
carbon
atom
surfac
surfacefunction
carbon
nanotub
intern
within
mammalian
cell
shi
kam
et
al
much
work
carbon
nanotub
involv
composit
materi
exampl
temperaturestabil
hydrogel
bioactiv
deliveri
applic
incorpor
carbon
nanotub
li
et
al
hand
fulleren
also
shown
bioactiv
target
capabl
tissueselect
target
well
intracellular
target
mitochondria
shown
use
fulleren
structur
furthermor
experi
fulleren
also
shown
exhibit
antioxid
lin
et
al
antimicrobi
activ
tsao
et
al
carbon
nanostructur
contain
ferromagnet
materi
anoth
mean
bioactiv
target
nanocarri
inject
intraven
direct
use
extern
magnet
field
upon
travel
blood
vessel
region
interest
treatment
berri
curti
process
bioactiv
target
use
magnet
deliveri
system
base
competit
forc
exert
nanocarri
blood
flow
magnet
forc
gener
extern
appli
magnet
field
magnet
forc
exceed
linear
blood
flow
rate
arteri
cm
capillari
cm
nanocarri
retain
target
site
intern
cell
target
tissu
tartaj
et
al
particl
small
enough
remain
circul
inject
pass
via
capillari
system
organ
tissu
avoid
vessel
embol
nanocarri
surfac
graft
cooh
group
acid
treatment
bioactiv
molecul
target
ligand
coval
attach
nanocarri
via
carboxyl
group
fig
ligand
attach
nanocarri
recogn
individu
compon
characterist
cellsurfac
antigen
berri
curti
wozniak
et
al
morpholog
cytotox
magnet
carbon
nanoparticl
recent
evalu
wozniak
et
al
use
invert
microscop
atom
forc
microscopi
afm
modern
nanocarri
system
nanoliposom
niosom
solid
lipid
nanoparticl
saup
rade
well
silicon
carbonand
polymerbas
nanocarri
play
import
role
control
deliveri
bioactiv
agent
desir
site
action
limit
side
effect
nontarget
site
ruozi
et
al
develop
nanosystem
requir
ration
character
approach
certain
paramet
pertain
newli
develop
nanocarri
system
must
thoroughli
assess
approv
clinic
applic
case
liposom
instanc
paramet
critic
import
vivo
perform
morpholog
size
polydispers
index
number
lamella
zeta
potenti
bilay
fluiditi
lipid
composit
encapsul
effici
carrierbioact
interact
chemic
stabil
must
studi
variou
analyt
techniqu
appli
dynam
light
scatter
dl
also
known
photon
correl
spectroscopi
pc
use
determin
particl
size
distribut
nuclear
magnet
reson
nmr
electron
paramagnet
reson
epr
appli
investig
lamellar
permeabl
bilay
influenc
particl
size
bioactiv
transport
recent
review
see
ruozi
et
al
microscop
approach
commonli
use
character
structuremorphologygeometri
nanocarri
electron
microscopi
techniqu
wide
use
measur
size
size
distribut
particl
sever
electron
microscopi
techniqu
employ
nanocarri
research
includ
scan
electron
microscopi
sem
ii
transmiss
electron
microscop
tem
iii
neg
stain
electron
microscopi
nsem
iv
freez
fractur
transmiss
electron
microscopi
fftem
particular
tem
provid
inform
size
distribut
shape
nanocarri
system
addit
configur
nanocarri
electron
microscopi
also
provid
inform
interact
particl
eg
form
aggreg
fusion
differ
type
nanocarri
eg
case
liposom
mlv
ulv
mvv
type
see
fig
differ
phase
carrier
eg
discom
polyhedr
niosom
locat
bioactiv
respect
carrier
eg
intern
attach
surfac
stabil
carrier
system
time
compar
electron
microscop
sem
less
frequent
use
imag
techniqu
particularli
liposom
research
howev
sever
sem
micrograph
show
cell
absorb
liposom
publish
use
determin
mechan
cellliposom
interact
eg
see
vinay
et
al
unfortun
nanocarri
may
suffer
structur
perturb
result
high
vacuum
condit
stain
process
requir
electron
microscop
see
fig
previou
year
besid
progress
sampl
prepar
microscop
techniqu
develop
atom
forc
microscopi
afm
one
techniqu
belong
famili
scan
probe
microscop
spm
dimension
resolut
approach
revolution
imag
nanosampl
bin
et
al
santo
castanho
attract
characterist
spm
potenti
imag
sampl
subnanomet
spatial
resolut
physiolog
condit
provid
inform
physic
mechan
properti
spm
techniqu
scan
tunnel
microscop
stm
invent
binnig
cowork
binnig
et
al
binnig
et
al
sinc
becom
establish
power
tool
studi
microand
nanoscal
structur
compar
type
microscopi
stm
uniqu
characterist
includ
ultrahigh
resolut
atom
dimens
ii
threedimension
imag
high
resolut
especi
vertic
direct
iii
varieti
oper
condit
vacuum
air
liquid
iv
observ
rang
micromet
angstrom
v
abil
tunnel
spectroscopi
feng
et
al
fig
depict
threedimension
stm
imag
doublestrand
dna
molecul
major
minor
groov
dna
visibl
fig
repres
stm
imag
twomonth
old
nanoliposom
present
fig
nanoscal
imag
enabl
character
nanocarri
includ
evalu
size
stabil
indic
size
morpholog
variat
time
eg
see
mozafari
et
al
afm
hand
develop
sinc
appli
imag
surfac
differ
materi
includ
ceram
metal
addit
biolog
pharmaceut
sampl
bin
et
al
mozafari
et
al
ruozi
et
al
santo
castanho
afm
abil
explor
sampl
varieti
environment
condit
includ
biolog
specimen
aqueou
physiolog
environ
air
differ
temperatur
control
humid
make
versatil
character
techniqu
addit
possibl
studi
sampl
low
temperatur
use
cryoafm
prater
et
al
shao
et
al
unlik
electron
microscop
method
often
requir
sophist
sampl
prepar
procedur
sampl
prepar
afm
easi
fast
allow
materi
preserv
nativ
state
mozafari
et
al
afm
oper
number
differ
imag
mode
depend
natur
interact
tip
sampl
surfac
scan
carri
keep
approxim
constant
distanc
probe
sampl
afm
oper
contact
mode
new
gener
afm
also
use
anoth
scan
mode
call
tap
mode
macmod
santo
castanho
tap
mode
afm
provid
highresolut
topographi
imag
minim
damag
sampl
surfac
applic
addit
measur
mode
later
forc
mode
lfm
forc
modul
mode
fmm
possibl
afm
ruozi
et
al
addit
topograph
imag
especi
consid
versatil
oper
mode
afm
also
provid
inform
regard
micromechan
properti
surfac
adhes
forc
ruozi
et
al
spm
studi
phospholipid
bilay
exampl
provid
valuabl
insight
micromechan
properti
biomembran
liang
et
al
well
biolog
process
format
pili
bacteri
conjug
maeda
et
al
case
electron
microscop
spm
techniqu
also
enabl
investig
particleparticl
interact
aggreg
fusion
process
characterist
certain
nanocarri
uvarov
et
al
furthermor
stm
particular
use
determin
bilay
thick
liposom
nanoliposom
niosom
archaeosom
analyt
abil
vertic
axi
zarei
et
al
anoth
use
applic
microscop
techniqu
gener
spm
particular
due
high
resolut
identifi
densiti
spatial
distribut
ligand
polym
peptid
antibodi
molecul
anchor
surfac
nanocarri
explain
ligand
equip
nanocarri
specif
target
mechan
ration
develop
nanocarri
bioactiv
deliveri
system
essenti
character
system
particl
evalu
nanocarri
morpholog
includ
character
shape
structur
surfac
morpholog
size
measur
particl
evalu
size
distribut
nanocarri
import
studi
physicochem
properti
stabil
prepar
also
identifi
vivo
kinet
system
particular
abil
cross
vessel
wall
accumul
target
tissu
eg
tumor
infect
site
order
exert
desir
effect
determin
nanocarri
size
distribut
obligatori
qualiti
control
assay
due
follow
reason
size
distribut
bioactiv
deliveri
formul
import
paramet
respect
physic
properti
stabil
goren
et
al
ii
size
distribut
along
composit
defin
plasma
pharmacokinet
biodistribut
stabil
nanocarri
associatedentrap
substanc
plasma
organ
barenholz
amselem
iii
nanocarri
size
major
factor
permeat
tumor
microvessel
local
resid
tumor
tissu
nagayasu
et
al
iv
pulmonari
applic
deposit
region
bioactiv
carrier
depend
mainli
densiti
shape
size
particl
mozafari
et
al
current
use
particl
size
determin
techniqu
advantag
limit
light
scatter
exampl
provid
cumul
averag
inform
size
larg
number
particl
simultan
howev
provid
inform
shape
nanosystem
assum
aggreg
one
particl
one
singl
particl
spm
microscop
fig
two
threedimension
scan
tunnel
micrograph
nanoliposom
deposit
hopg
highli
orient
pyrolyt
graphit
dri
room
temperatur
atmospher
pressur
nanoliposom
indic
arrow
prepar
heat
method
two
month
prior
imag
techniqu
hand
make
direct
observ
possibl
henc
provid
inform
shape
nanocarri
well
presenceabs
aggreg
fusion
mozafari
et
al
drawback
microscop
investig
number
particl
studi
certain
time
limit
respect
statist
meaning
analysi
size
distribut
nanocarri
method
light
scatter
measur
averag
size
larg
number
particl
appropri
microscop
techniqu
mozafari
mortazavi
note
spm
techniqu
assess
sampl
liquid
adsorb
solid
surfac
partial
fulli
dehydr
light
scatter
method
evalu
particl
suspens
gener
approach
determin
size
distribut
nanocarri
formul
henc
use
mani
differ
techniqu
possibl
least
combin
highresolut
imag
particl
size
techniqu
togeth
gain
knowledg
respect
diseas
pathophysiolog
cellular
mechan
specif
bioactiv
materi
develop
use
specif
potenc
bioactiv
new
carrier
system
must
exploit
nanostructur
deliveri
system
promis
candid
enabl
effici
target
deliveri
novel
bioactiv
compound
systemat
character
nanocarri
one
main
step
evalu
present
come
applic
respect
microscop
approach
enabl
direct
visual
provid
valuabl
inform
geometri
morpholog
size
distribut
superfici
properti
nanocarri
affect
interact
bioactiv
materi
target
cell
microscop
techniqu
gener
spm
particular
enabl
us
identifi
densiti
spatial
distribut
target
ligand
polym
peptid
antibodi
molecul
anchor
surfac
nanocarri
local
way
nanocarri
interact
bioactiv
materi
import
obtain
good
vivo
applic
moreov
forc
measur
anoth
interest
properti
highresolut
microscop
spm
provid
signific
inform
elast
chemic
adhes
properti
nanocarri
inform
obtain
highresolut
imag
techniqu
crucial
ration
design
formul
optim
nanocarri
system
use
modern
field
nanotherapi
